United Airlines Holdings (NASDAQ:UAL) is a stock to watch as U.S. markets reopen after Labor Day. The company's core business revolves around global passenger aviation with a large hub-and-route network, placing it within the value stocks category. Key factors influencing its performance include mature operations, cost control, balance-sheet discipline, and adapting to changing demand conditions, alongside broader inflation and interest rate expectations.

StoneX has reiterated a buy rating and a $270.00 price target for Qualcomm (NASDAQ: QCOM) following its new partnership with Amazon. This collaboration involves customized silicon for AI inference and optical connectivity, materially validating Qualcomm's data-center platform. Despite varying analyst perspectives, the firm maintains its positive outlook, highlighting Qualcomm's diversification beyond mobile chips and its stock's apparent undervaluation.

HP has announced a collaboration with Red Hat and NVIDIA to extend enterprise AI capabilities from the data center to the edge. This partnership aims to create an open, enterprise-grade AI platform combining HP ZGX Fury with Red Hat AI Factory and NVIDIA technology, designed to run AI inference closer to users and data. The initiative seeks to improve local AI inference throughput, reduce setup time, and enhance GPU utilization for various industries.

Analog Devices has announced its agreement to acquire Alif Semiconductor for $1.35 billion in cash. This acquisition aims to expand Analog Devices' presence in rapidly growing markets like data-center infrastructure and defense, capitalizing on the evolving landscape of artificial intelligence. Both companies' boards have approved the deal, which is expected to close by year-end.

Revvity, Inc. has announced its definitive agreement to acquire Human Cell Design (HCD), a French biotech company specializing in human cell models for metabolic diseases. This acquisition will integrate HCD's human pancreatic beta cell models, including their flagship EndoC-βH5 model, into Revvity's Life Sciences portfolio to enhance drug discovery and preclinical research for conditions like diabetes and obesity. The move aims to provide more human-relevant approaches for understanding biology, especially for GLP-1 and GPCR-targeting therapies, and is expected to close in Q4 2026.

The Ontario government is investing in the relocation of a Canadian National Railway Company (CN) rail line to facilitate the widening of Highway 69 from two to four lanes. This relocation, which is the first step in accelerating the project, will enable the construction of a new interchange at Highway 522. So far, 84 kilometers of the 152-kilometer corridor have been widened.

Evercore ISI has increased its price target for FedEx (FDX) stock to $350 from $323, while maintaining an "In Line" rating, due to the company's ongoing business transformation and path to $6 billion in free cash flow by 2029. The adjustment follows a meeting with FedEx's CEO and investor relations team, and comes as other firms like Raymond James and Citizens also issued positive ratings and price targets for FDX. The stock has shown a 75% return over the past year, reflecting investor confidence in its transformation potential.

This article examines Sherwin-Williams (NYSE:SHW) as US markets reopen, focusing on its position within blue-chip stocks. The company, known for its coatings and paint products, is evaluated based on its large-scale operations, durable franchises, broad customer reach, and disciplined execution. The report emphasizes the importance of business fundamentals and company-specific execution in the current market environment, where rate expectations and commodity moves can significantly influence sector performance.

Independence Realty Trust (IRT) and Centerspace have agreed to merge in an all-stock transaction valued at approximately $8.1 billion, creating a multifamily REIT with a pro forma equity market capitalization of about $5 billion. The deal combines IRT's Sunbelt portfolio with Centerspace's Midwest and Mountain West communities, aiming for increased scale, efficiency, and access to capital markets. The merger, expected to close by the end of Q4 2026, still requires shareholder and lender approvals.

Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) announced the preliminary results of its substantial issuer bid to repurchase up to US$70,000,000 of its common shares at US$25.00 per share. The company expects to purchase 99,332 common shares for an aggregate consideration of US$2,483,300, funded from cash on hand. After the offer, approximately 24,947,594 common shares are expected to be issued and outstanding.